INTRA CELLULAR THERAPIES INC
Industry: Biotechnology (See others in industry)
Address:
Audubon Biomedical Science & Technology Park, 3960 Broadway
New York, NY, 10032
Phone: 212-923-3344
New York, NY, 10032
Phone: 212-923-3344
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2013-09-11 | New | $60,000,000 | $60,000,000 | Equity Only | 06 | SEC link |
| 2013-06-25 | Amended | $15,289,893 | $0 | Debt Only | 06 | SEC link |
| 2013-06-25 | New | $241,633 | $241,633 | Equity Only | 06 | SEC link |
| 2013-05-17 | Amended | $15,289,893 | $0 | Debt Only | 06 | SEC link |
| 2013-04-01 | New | $15,289,893 | $15,289,893 | Debt Only | 06 | SEC link |
| 2010-03-08 | New | $5,335,780 | $5,335,780 | Equity Only | 06 | SEC link |
| 2007-11-06 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-02-01 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Christopher Alafi | Director |
| Allen Fienberg | Executive |
| Lawrence Hineline | Executive |
| David Kipnis | Director |
| Richard Lerner | Director |
| Joel Marcus | Director |
| Sharon Mates | Director, Executive |
| Sir Michael Rawlins | Director |
| Michael Rawlins | Director |
| Kimberly Vanover | Executive |
| Lawrence Wennogle | Executive |